Canlyniadau Chwilio - Lincoff, A Michael

Antithrombotic therapy with intracoronary stenting gan Steinhubl, Steven R, Lincoff, A Michael

Cael y testun llawn Cael y testun llawn

Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis gan Hoogwerf, Byron J., Lincoff, A. Michael, Rodriguez, Angel, Chen, Lei, Qu, Yongming

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Successful treatment of aortic root dissection complicated with extensive myocardial infarction using the total artificial heart gan Attia, Tamer, Robich, Michael, Lincoff, A. Michael, Shishehbor, Mehdi H., Svensson, Lars, Smedira, Nicholas G.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis gan Riaz, Haris, Khan, Safi U, Rahman, Hammad, Shah, Nishant P, Kaluski, Edo, Lincoff, A Michael, Nissen, Steven E

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Drug-Eluting Stents versus Bare-Metal Stents for Treatment of Bare-Metal In-Stent Restenosis gan Singh, Inder M., Filby, Steven J., Sakr, Fredy El, Gorodeski, Eiran Z., Lincoff, A. Michael, Ellis, Stephen G., Shishehbor, Mehdi H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phas... gan Ruilope, Luis, Hanefeld, Markolf, Lincoff, A Michael, Viberti, Giancarlo, Meyer-Reigner, Sylvie, Mudie, Nadejda, Wieczorek Kirk, Dominika, Malmberg, Klas, Herz, Matthias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular Surgery gan Reed, Grant W., Horr, Samuel, Young, Laura, Clevenger, Joshua, Malik, Umair, Ellis, Stephen G., Lincoff, A. Michael, Nissen, Steven E., Menon, Venu

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial gan Mani, Preethi, Puri, Rishi, Schwartz, Gregory G., Nissen, Steven E., Shao, Mingyuan, Kastelein, John J. P., Menon, Venu, Lincoff, A. Michael, Nicholls, Stephen J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis gan Khan, Safi U., Rahman, Hammad, Okunrintemi, Victor, Riaz, Haris, Khan, Muhammad Shahzeb, Sattur, Sudhakar, Kaluski, Edo, Lincoff, A. Michael, Martin, Seth S., Blaha, Michael J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction gan Nair, Raunak, Johnson, Michael, Kravitz, Kathleen, Huded, Chetan, Rajeswaran, Jeevanantham, Anabila, Moses, Blackstone, Eugene, Menon, Venu, Lincoff, A. Michael, Kapadia, Samir, Khot, Umesh N.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes gan Kumbhani, Dharam J, Wells, Brian J, Lincoff, A Michael, Jain, Anil, Arrigain, Susana, Yu, Changhong, Goormastic, Marlene, Ellis, Stephen G, Blackstone, Eugene, Kattan, Michael W

Cael y testun llawn Cael y testun llawn

Comparison of Clinical Trial Outcome Patterns in Patients Following Acute Coronary Syndromes and in Patients With Chronic Stable Atherosclerosis gan Mahaffey, Kenneth W., Wojdyla, Daniel M., Pieper, Karen S., Tricoci, Pierluigi, Alexander, John H., Lincoff, A. Michael, Brennan, Danielle M., Bhatt, Deepak L., Wallentin, Lars, Harrington, Robert A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Smoking, Clopidogrel, and Mortality in Patients with Established Cardiovascular Disease gan Berger, Jeffrey S., Bhatt, Deepak L., Steinhubl, Steven R., Shao, Mingyuan, Steg, P. Gabriel, Montalescot, Gilles, Hacke, Werner, Fox, Keith A., Lincoff, A. Michael, Topol, Eric J., Berger, Peter B.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinica... gan Vandvik, Per Olav, Lincoff, A. Michael, Gore, Joel M., Gutterman, David D., Sonnenberg, Frank A., Alonso-Coello, Pablo, Akl, Elie A., Lansberg, Maarten G., Guyatt, Gordon H., Spencer, Frederick A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial gan Koomen, Jeroen V., Heerspink, Hiddo J. L., Schrieks, Ilse C., Schwartz, Gregory G., Lincoff, A. Michael, Nicholls, Stephen J., Svensson, Anders, Wedel, Hans, Weichert, Arlette, Grobbee, Diederick E., Stevens, Jasper

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of th... gan Puri, Rishi, Nissen, Steven E., Arsenault, Benoit J., St John, Julie, Riesmeyer, Jeffrey S., Ruotolo, Giacomo, McErlean, Ellen, Menon, Venu, Cho, Leslie, Wolski, Kathy, Lincoff, A. Michael, Nicholls, Stephen J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study gan Nissen, Steven E., Pillai, Sreekumar G., Nicholls, Stephen J., Wolski, Kathy, Riesmeyer, Jeffrey S., Weerakkody, Govinda J., Foster, Wendra M., McErlean, Ellen, Li, Lin, Bhatnagar, Pallav, Ruotolo, Giacomo, Lincoff, A. Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial gan Kumar, Anirudh, Patel, Divyang R., Brennan, Danielle M., Wolski, Kathy E., Lincoff, A. Michael, Ruotolo, Giacomo, McErlean, Ellen, Weerakkody, Govinda, Riesmeyer, Jeffrey S., Nicholls, Stephen J., Nissen, Steven E., Menon, Venu

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Genome-wide Polygenic Score and Cardiovascular Outcomes with Evacetrapib in Patients with High-risk Vascular Disease: A Nested Case-control Study gan Emdin, Connor A., Bhatnagar, Pallav, Wang, Minxian, Pillai, Sreekumar G., Li, Lin, Qian, Hui-Rong, Riesmeyer, Jeffrey S., Lincoff, A. Michael, Nicholls, Stephen J., Nissen, Steven E., Ruotolo, Giacomo, Kathiresan, Sekar, Khera, Amit V.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy gan Menon, Venu, Kumar, Anirudh, Patel, Divyang R., John, Julie St., Wolski, Kathy E., McErlean, Ellen, Riesmeyer, Jeffrey S., Weerakkody, Govinda, Ruotolo, Giacomo, Cremer, Paul C., Nicholls, Stephen J., Lincoff, A. Michael, Nissen, Steven E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn